CA1326330C - Intraocular lenses - Google Patents

Intraocular lenses

Info

Publication number
CA1326330C
CA1326330C CA000552538A CA552538A CA1326330C CA 1326330 C CA1326330 C CA 1326330C CA 000552538 A CA000552538 A CA 000552538A CA 552538 A CA552538 A CA 552538A CA 1326330 C CA1326330 C CA 1326330C
Authority
CA
Canada
Prior art keywords
lens
iol
accordance
temperature
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000552538A
Other languages
French (fr)
Inventor
Vladimir A. Stoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kingston Technologies Inc
Original Assignee
Kingston Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kingston Technologies Inc filed Critical Kingston Technologies Inc
Application granted granted Critical
Publication of CA1326330C publication Critical patent/CA1326330C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1616Pseudo-accommodative, e.g. multifocal or enabling monovision
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1662Instruments for inserting intraocular lenses into the eye
    • A61F2/1664Instruments for inserting intraocular lenses into the eye for manual insertion during surgery, e.g. forceps-like instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C61/00Shaping by liberation of internal stresses; Making preforms having internal stresses; Apparatus therefor
    • B29C61/06Making preforms having internal stresses, e.g. plastic memory
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/02Artificial eyes from organic plastic material
    • B29D11/023Implants for natural eyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/16Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2011/00Optical elements, e.g. lenses, prisms
    • B29L2011/0016Lenses
    • B29L2011/0041Contact lenses

Abstract

ABSTRACT OF THE DISCLOSURE
There is provided a novel intraocular lens and mode of insertion therefore. The lens is of conventional shape and dimensions but is made of polymeric material having a softening point in the range of body temperature. The lens, prior to insertion is dimensionally reduced to enable introduction thru a small incision by compression or by axial extension. The deformed lens is frozen in this configuration by cooling the lens below its softening temperature. The cooled, deformed lens is then inserted into the eye. The action of body heat, optionally supplemented by various non-harmful methods, permits the lens to regain its original configuration within the eye.

Description

1 3~6330 ~O~L~
An intraocular lens (IOL) is an optical device which iB
implanted into the anterior chamber (i.e., anterior to iris) or posterior chamber of the eye to replace the natural crystalline lens damaged by cataract, injury, etc.
IOLs are usually made mostly of clear acrylic resin (poly-methylmethacrylate or PMMA), a rigid, glassy polymer. Since the PMMA IOL i8 about 6 mm in diameter in the narrowest axial cross-section (i.e., the plane including optical axis), the incision haa to be appropriately large.
New 6urgical techniques and instruments allow for removal of the cloudy natural crystalline lens (i.e., cataract) through a much 6maller incision than 6 mm (typically 2-3 mm). The major advantages of the small incision are lesser trauma, lower loss of intraocular pressure and aqueous humor during the 6urgery, easier healing and lesser ri6k of astigmation due to scar contractlon.
In addition, these techniques (e.g., facoemulsification) permit only partial removal of the lens. Only the opacified geleous substance need be removed, while the lens capsule, or at least its posterior part, is left intact. The lens capsule is then utilized to keep the IOL in the proper location or, it can be even refllled by a sultable medium to restore its optlcal function.
~'' .

-- .

~ : : ' ' ,.... .

~ .

DESCRIPTION OF THE RELATED ART
The techniques and instruments for such procedures are described, for instance, in U.S. Patent Nos. 3,589,363;
4,063,557; 3,996,935: 4,078,564: and 4,191,176. The vacant capsule can be filled either with liquid (U.S. Patent Nos.
3,996,935 and 4,002,169; or U.S.S.R. Patent No. 570,363), or with a 8il icone elastomer (U.S. Patent Nos. 4,537,943 and 4,542,542) to renew its optical function.
The advantages of the facoemulsification cannot be fully utilized if the IOL cannot be inserted through a small incision.
For this reason, a number of IOL designs and surgical techniques were proposed and tested. Some of the IOL designs are made from : flexible materials such as silicone rubber or covalently cross-linked hydrogels.
For instance, U.S. Patent No. 4,253,199 (A. Banko) describes a deformable IOL prepared from soft, elastomeric materials, such as hydrogels. U.S. Patent No. 4,206,518 (F. Jardon, et al.) as well as U.S. Patent No. 1,198,131 (Birdsall, et al.) describe IOLs made of a medical grade silicone elastomer.
U.S. Patent No. 4,254,509 (J.L. Tennant) describes an IOL
made at least partly from elastomeric materials such as hydrogels. According to CATARACT (April, 1984, pp. 18-19) PHEMA
hydrogel lenses which are partially hydrated before insertion, have been used as IOLs since 1976.

.

Although the above flexible lenses were not designed specifically for facoemuls~fication procedure, the concept of facilitating insertion by using a flexible IOL is indicated in several sources.
U.S. Patent No. 4,573,998 (T.R. Mazzoco) describes a method for the placement of an IOL through a small insertion by using an IOL made from an elastic material and deforming the IOL while it is being inserted. Usually the IOL is deformed by folding it into a "taco" 6hape.
The disadvantage of this approach iB that folding the IOL
requires considerable deformation in the center of the optical zone which, in turn, can cause permanent deformation and various other defects, such as crease marks and the like.
The use of softer materials which could be easily deformed without causing a permanent deformation causes another problem.
Very soft materials have little incentive to entirely unfold to their original 6hape in the highly viscous intraocular environment. In addition, the lens folding and its manipulation in the folded state is highly 6ensitive to the individual sUrgeon~s 6kill. Even more importantly, simple folding is not suitable for maximum decrease of lens cross-section during insertion. Adjacent surfaces of the lens cannot be entirely br~ught together (because this would cause maximum deformation in the cptical zone~ and an instrument ha~ to be used to keep the . . . -, :
-.. . . . . . . .

~-.: ~ .

lens folded durlng the insertion so that the IOL penetrates through the incision. The instrument together with the lens, effectively increases the lens cross-section.
The more convenient modes of deformation are not readily achievable in practice for an elastomeric lens, since the instrument needed for deformation is also the insertion instrument. For this reason, various other approaches have been suggested which do not depend on simple folding or rolling.
For instance, U.S. Patent No. 4,373,218 (R.A. Schacher) describes an inflatable IOL which can be inserted in a folded and deflated state through a small incision. Another approach i6 the insertion of a deswollen hydrogel lens which swells in place by - imbibing water from 6urrounding aqueous humor. The disadvantage here is that a substantial water content i8 needed to achieve the needed dimensional change. If the swelling is isotropic, the IOL
has to swell 8 times by volume to increase its diameter from about 3 mm in the dry state, the 6ize of the incision, to 6 mm, the u~ual 6ize of an IOL. Therefore, the lens has to contain about 85% water (by volume) in its final state. However, most hydrogels are 6tructurally weak at such a high water content.
More importantly, the refractive index of such hydrogel i6 low (about 1.36 in the above example), so that the lens surface has to be more curved and hence, the lens has to be thick in the center to achieve the required refractive power. For this basic rea60n, the deswelling itself is not enough to permit insertion :' . . ,~ ~ '. .

. ~ . . . . . .

through a small incision. It is necessary to reshape the IOL in its non-swollen state so that the swelling simultaneously changes the volume and shape of the IOL.
One method proposed to achieve this aim i~ to design the IOL
as a capsule composed of strong eemipermeable membranes with a highly swellable gel or a water-soluble polymer entrapped in the capsule.
According to U.S~ Patent No. 4,46~,705 (P.E. Nichaelson), the dry lens can be folded for insertion into the eye, and then unfolded and blown into biconvex shape by osmotic pressure in the capsule. The potential disad~antage of this solution i8 the fact that the concentration of the polymer inside the capsule has to - be rather high (at least 40-50~) to achieve the required refractive index (about 1.40). Accordingly, the pressure inside the capsule is permanently high. Although it i6 claimed that the membranes are sufficiently strong to withstand the resulting pre6sure of several tens of p. B. i., the presence of the pressurized capsule presents a certain long-term hazard. In addition, the optical properties which are dependent on the swelling are rather difficult to control.
Another method i5 the use of a hydrogel which is rigid enough in the non-swollen state to keep a ~hape ~uitable for insertion, but flexible and swellable enough to return to its inherent shape once it is inserted and fully swollen. Such a lens and method of surgery is described in U.S. Patent No.

: .:
- ;

-~ 1 32633~

.
4,556,998 (S.B. Siepser). One obvious advantage of this approach is that the final swelling does not need to be high because the decrease of cross-section i5 achieved by a simultaneous change of shape and increase in 6ize. For instance, the lens can be dried in a longitudinally extended shape BO that its lateral cross-section is 6ubstantially decreased. The cross-section can be also changed into other than lenticular shapes (e.g., circular, rectangular, elliptical, etc.) which are more suitable ~or insertion.
An additional advantage of this IOL in comparison with the deformation of an ela6tic IOL iB that a rigid lens can be readily manipulated during the insertion and an instrument (6uch as _ fOrCepB) iB not needed in order to maintain the deformed 6hape of the lens. Accordingly, the instrument does not need to be inserted into the incision simultaneously with the lens.
The concept of IOL 6welling in 6itu has several lnherent disadvantages. The most 6erious one is that the under6wollen hydrogel i~ not in thermodynamic equilibrium with vitreous humor or ti~sue~ in its vicinity. AB the hydrogels imbibe water from the environment, they concentrate proteins and other vitreous components on the interface. This can, in turn, cause protein denaturation, irreversible sorption and related biocompatibility problems. If such underswollen hydrogel contacts tissue, it adheres to the tissue and tends to destroy cell6 it contacts by breaking their membranes or ~imply tearing them off.

: - . ~:. , - j .
: , ,, . ~ . . . , . ~ - .
~- ,. - ~ . -, . . ~

This cannot be readily prevented merely by the use of viscoelastic lubricating agent6 such as hyaluronic acid solutions. Such a solution can trigger the 6welling and relaxation prematurely, a matter which is difficult to control in practice. Furthermore~ if the viscoelastic 601ution becomes more concentrated as it loses the water to the hydrogel, its lubricating properties decrease as well. Another disadvantage of 6welling in situ is that the full 6welling takes considerable time. Thus, its result6 a6 to vi~ion, fixation, etc. cannot be lo checked and eventually corrected during surgery.
Still another di6advantage is that the IOL cannot be 6terilized by heat ~ince the heating above a certain temperature _ would trigger relaxation and 6hape changes which have the samenegative effects as premature 6welling. Autoclaving is even less de6irable than dry-heat 6terilization, 6ince the 6team would cause both 6welling and relaxation. Other method6 of terilization, such aæ ethylene oxide or gamma-irradiation, would pose their own 6pecific problems.

SUMMARY OF THE INVENTION
There is provided an intraocular lens arrangement comprising a non-toxic, biocompatible, hydrolytically and enzymatically stable, photodegradation re6i6tant, polymeric optical zone portion. The polymeric material of the intraocular lens arrangement, when in oæmotic equilibrium with aqueous humor, has the following characteristic6:

,~ ,. . .

, , "` t ,: ` : ' : . : ' :

': : - ' ;

Softening temperature T6 between about 0C a~d about 42C, preferably between about +10 and +30C.
Damag~ng temperature Td above 42~C. A refractive index greater than 1.39. The polymeric material can be heated in its temperature range of elastic deformation Tel above T8 but below Td, without damage.
The polymeric optical zone portion of the lens will return to its original dimension at a temperature Te which is above Ts and below Td under the following conditions:
Initial deformation of the optical zone by reducing a given dimension by at least 20%, using pressure or transverse stretching, at a temperature T5 or above, but le68 than Td.
_ Cooling the optical zone to at lea~t 5C to 10C below Td to maintain deformation. Reheating the polymeric optical zone of the lens to Te~ allowing it to return to its original dimensions prior to its initial deformation.
T6 is the softening temperature at which the polymer may be readily deformed but at or above which it will readily return to lt6 previous shape upon release of the deforming force. Td is the temperature above which the polymer wîll be permanently deformed and damaged. The designation of Ts and Td as definite temperatures is inexact for most polymers. The effect takes place within about + 3C of a designated temperature.
At temperatures above T8 and in the absence of outside deforming forces, the intraocular lens exists in a shape designed as the Optical Configuration (OC) in which it has at,least one - . ..- . .

, -convex surface which is symmetrical along the optical axis.
Preferably, the lens has a refractive power from about +10 to about +35 Diopters in an aqueous immersion, and has an optical zone diameter from about 5 to about 9 mm. In the absence of outside deforming forces, the Optical Configuration of the IOL is maintained even if it is cooled below Tg.
The IOL according to this invention, can be reshaped into the Insertion Configuration (IC) which has a shape different from that of the Optical Configuration and which i8 6elected to optimize insertion into the eye regardless o its optical properties.
Pr~ferably, the shape of the IC iB such that any cross-_ section lateral to a selected direction has an area smaller than about 4 mm2, and more preferably smaller than 2.5 mm2. Also, any linear dimeneion of ~uch cross-section is smaller than 3.5 mm and preferably smaller than 2.5 mm.
The IOLs according to this invention can be temporarily reshaped into the IC by applying a suitable s~ress at a temperature higher than Ts, preferably between about 40C and about 100C.
Once reshaped into IC, the IOL is cooled down to a temperature below Tg, preferably to a temperature between about `
-5C and about (TS-5)C. The IOL in the IC at such a temperature is essentially undeformable, rigid and capable of maintaining its shape during its insertion into the eye, without the need to apply outside forces or cause a deformation of any kind.

After the IOL is inserted and properly placed in the eye, it returns into its inherent Optical Configuration after its temperature reaches body temperature which is higher than Ts.
Preferably, the polymeric material can be plastizable by water or i6Otonlc a~ueous 601utions containing biocompatible solutes. The polymeric material is a co-polymer derived from at least two co-monomers, wherein at least one of the co-monomers is hydrophilic and the other may be hydrophobic.
It is often desirable that the copolymer additionally comprises a cross-linking agent. It may also comprise an outer hydrogel layer capable of maintaining a water content greater than 90% by weight when inserted in the eye.
_ The invention also includes a sterile package comprising a lens as previously described, packaged with a clamping or stretching means. The clamping or stretching means i6 used for reshaping the lens into the IC at a temperature above Ts and below Td. The 6terile package also includes an autoclavable encapsulating means surrounding the lens and the clamping or stretching means.
In one embodiment of the package, the lens iB located within the clamping or 6tretching means, in its inherent optical configuration ~i.e., unshaped). Alternatively, the lens in the package has been reshaped into the IC and it is maintained in this configuration by the clamping or stretching means.

.
- : . - : . . ..

1 32633~
.
The invention also lncludes a method of introducing and implantin~ an artificial intraocular lens through an incision in the eye for replacement of a surgically removed natural crystalline lens, comprising the steps of:
a) proviaing an intraocular lens as previously described;
b) increasing the temperature of said lens to or above Ts but below Td of the polymer;
c) reshaping the lens at this temperature into Insertion Configuration as defined above;
d) cooling the lens to a temperature between about -5C, and 5 to 10C les~ than T6, while maintaining ~aid IC;
e) inserting said len~ in the IC at a temperature lower - than T6, es6entially in a rigid and non-elastic state, through an incision in the eye at a location posterior or anterior with respect to the ir1s; and, f) allowing the lens to be warmed to the temperature of the eye, above Ts, 60 that the lens will resume its Optical Configuration to provide safer, le6s traumatic and more convenient surgical procedure.
The dimensional reduction of the lens may be achieved at a temperature at or above Ts, but less than Td, either by extension along a longitudinal axis of the lens or compression transverse to a longitudinal axis or a combination of both.

.

~ 1 326330 BRIEF DESCRIP~ION OF THE DRAWINGS
Fig. lA is a plan view of the optical zone of the lens of the present invention in its undeformed optical configuration.
Fig lA iB a cross-sectional view of the lens illustrated in Fig. lA taken through line lA'-lA' in the direction of the arrows.
Fig. lB is a plan view of the optical zone of the lens illustrated in Fig. lA in the Insertion Configuration which is achieved by compression of the lens.
Fig. lB' is a cross-sectional view of the lens illustrated in Fig. lB taken through line lB'-lB' in the direction of the arrows.
_ Fig. lC i6 a plan view of the optical zone of the lens illustrated in Fig. lA in the Insertion Configuration which is achieved by extension of the lens.
Fig. lC' is a cross-sectional view of the lens illustrated in Fig. lC taken through line lC'-lC' in the direction of the arrows.
~, A, V and D, are the length (i.e., maximum dimensions), the cross-sectional area, the volume and the dimension (transverse to L), respectively, of the optical zone of the lens.
The dimensions of the optical zone of the lens in the Optical Configuratlon are symbolized by an ~O~ and by a "d" in the Optical Configuration; where Do>Dd~ Ao~Ad~ Ld>Do and VO Vd-.

~ 1 326330 Figs. 2 thru 8 (A and B~ are plan and cross-sectional views, respectively, of several examples of the lens/haptic combinations usable in this inventlon.
Fig. 8BI is an alternate cross-sectional view of the lens/haptic combination illustrated in Fig. 8A.
Fig. 9 is a schematic cross-sectional view of a lens in a clamping means in the Optical Configuration.
Fig. lO is the schematic cross-sectional view of the lens in the clamping means illustrated in Fig. 9 shown in the Insertion Configuration, compressed in the direction of the arrows.

DESCRIPTION OF THE PREFERRED EMBODIMENTS
- The lntraocular lens 18 inserted lnto an lncislon ln the eye. The intraocular lens ls ln the Insertlon Conflguration (IC), preferably at a temperature lower than T6 (about 5C and more preferably by more than 10C) at which the polymer is essentlally rigid and non-ela6tlc and the IC is maintained without an applicatlon of an outside force.
The IC i6 the 6hape in which the IOL' 6 cross-section includlng lts optlcal axls, is preferably, smaller than about 4 mm2, and more preferably less than 2.5 mm2; and in which no linear cross-sectional dimenslon lateral to the lnsertion axiB iB
larger than about 3.5 mm, preferably less than 3 mm. The IC is imparted onto the IO~ by outside forces, preferably by ., : . .

- .
.

., compression in an appropriately shaped tool, at a temperature of about Ts, preferably at least 5C and more preferably at least 15C above Ts but below Td. The IC is maintained by cooling the IOL to a temperature below Ts~ preferably to at least 5C, more preferably to about 10C below Ts.
After the IOL is inserted in the eye and properly placed, it returns to its inherent Optical Configuration (OC) as its temperature reaches body temperature (higher than Ts). The body temperature i6, as a rule, between about 36 and 37C. Body temperature can be temporarily increased by 6everal degrees using various means, such as infrared heating, hot compresses or microwave irradiation. For the purpose of this invention, the _ "body temperature" 16 the highest temperature to which the intraocular temperature can be 6afely raised, even for a short period of time (42-43C).
The softening temperature (T6) i6 the lowest temperature at which the lens can be substantially deformed without breaking or fracturing, and return completely to its original shape when the outside pressure i6 released. Below Ts~ the material is essentially rigid and cannot return completely to its original shape by mens of its internal forces. T6 may correspond to glass-tran6ition temperature Tg which has a well known and well defined meaning. In some cases however, T6 and Tg are not identical, e.g., in cases of two-phase polymer system6, or the .

dual character of interaction between polymer cha~ns. In 6uch a case, Ts iB best defined as the lowest temperature at or above which there is no permanent residual deformation after removing a previously applied external 6tress. The recovery from deformed 5to inherent shape is not and need not be immediate. The complete recovery of 6hape can be achieved after a period as long as several hours without 6ubstantial problems. Although it is preferred that full recovery of 6hape take place in less than about 30 minutes, and more preferably in less than about 5 minutes.
The recovery to the original 6hape ie much slower below Ts than above Te~ 80 that it ie not complete even after a very long time perlod. The relaxatlon processes slows down considerably wlth decreaelng temperature so that at eeveral degrees below Ts, 15the polymer 1B rigid and doee not return into its inherent shape at any appreclable rate or extent. Due to the physical nature of the relaxation proces~, the transition between practically rigid and practically flexible state, extends over a certain range of temperatures rather than at a elngle ~harply deflned temperature.
20Accordingly, T6 le defined arbitr&rily with respect to the practical goals of thie invention.
In addition to having a Te in the above range, the material of thi6 invention is reguired to have good shape memory due to the presence of a covalent or strong physical network, and cannot .~
: ,.
, ,;..... , : - ~
. . :

suffer permanent deformation at temperatures higher than at least 37C. The polymer can be reversibly deformed at a temperature higher than Ts up to a ceiling temperature Td above which it iB
thermally damaged. Td is preferably higher than about 125C. In addition to the above requirements, the material must be highly transparent to visible light and have a refractive index hiqher than about 1.39 and preferably higher than about 1.45.
In addition, the material of this invention has to be biocompatible, non-toxic, hydrolytically and enzymatically stable, and resistant to photodegradation.
There are a considerable number of polymers and copolymers which meet the basic requirements of this invention, i.e., _ 1) T6 between 0 and 42C, preferably between 15 and 30C;
2) Optical clarity;
3) Refractive index over 1.39, preferably over 1.45;
4) Good shape memory and no permanent deformation above 36C and preferably above 30C;
5) Sufficient hydrolytic and enzymatic 6tability;
6) Photostability; and 7) Non-toxicity and biocompatibility.
The polymers with 6uch properties can be found among polyurethane~, polyureas, polyethers, polyester6, and the like.
Another class of polymers where 6uitable properties can be found are co-poly6iloxanes, particularly those with a high content of aromatic and/or highly polar 6ubstituents.

. . .

The preferred class of polymers are the polyacrylates and polymethacrylates, particularly those containing an appropriate combination of lower and higher alkyl acrylates to place Ts in the required range. Particularly useful is the group of copolymers containing C2 and C8 alkyl acrylates and methacrylates in combination with co-monomers with higher Tg~ such as methylmethacrylate, styrene, methyl-styrene, vinylpyrridine and similar copolymer6.
Still another useful class of copolymers are those containing N-alkyl and N,~-dialkyl acrylamides and methacrylamides.
It iB well known that the TB Of copolymers can be adjusted _ by combining co-monomers, one having Ts lower and the other higher than the target T8. Therefore, it i8 relativel~ easy for those skilled in the art to synthesize a large array of copolymers with T8 in the range useful for the present invention.
The temperature of 60ftening Ts can be decreased by the use of plasticizers. The concentration of plasticizer needed to decrease the T8 of a polymer below 37C depends on both the polymer and the plasticizer, but it iB usually below about 40% by weight and more often below about 20% by weight of the polymer/
plasticizer combination. The plasticizers useful ln the present invention must have a very low toxicity.- There are a number of plasticizers known to those skilled in the art which are su~table .
. .
- .. ~ .
, for medical appllcations. The pre~erred plaBticizier i8 water or an isotonic aqueous solution (saline, Ringer solution, plasma and the like).
There are a number of known polymers which do not substantially swell in water (as do hydrogels) but whose Tg or Ts is decreased by absorbed water. The specific polymers of this class which are 6uitable for the present invention are those whose Ts decreases in the presence of equilibrium concentration of water below 42C and preferably below 30C.
The numerous polymers capable of plastification by water are those having both hydrophilic and hydrophobic moieties in their structures. Examples of such polymers are derivatives of _ cellulose or certain copolymers and terpolymers containing hydrophilic and hydrophobic monomers. A particularly preferred co-polymer is a combination of at least two co-monomers composed of the following: A first monomer component which when polymerized forms a hydrophobic polymer with a Ts higher than 37C; and, a second monomer component which when polymerized forms a hydrophilic polymer or hydrogel. Because water itself depressed Tg of the hydrophilic moiety, the resulting copolymer can have T6 in the preferred range if plasticized with water, regardless of the TB f such copolymer in a dry state.
Furthermore, it is advantageous if the copolymer has high Ts in a dry state, while its Ts is below 37C when swollen to equilibrium. Such copolymers can be readily lathed and polished - ~ .: . , .
into optically perfect 6urfaces in the dry (xerogel) 6tate and then plasticized with water and reshaped into the IC prior to insertion.
Water-plasticized polymers or hydrogels have a number of advantages in comparison with hydrophobic polymers. For instance, they have a certain level of permeability for water and water-soluble compounds. Accordingly, they present less of a barrier to diffusion transport (which is often important for biocompatibility) than hydrophobic polymers. The same permeability facilities cleaning and extraction of low molecular weight compounds 6uch a6 residual monomers and the like, 60 that long-term leaching of toxic residuals i8 a lesser problem than in - the case of hydrophobic polymers.
The hydrophilic 6urface has a lesser tendency to absorb certain protein6, ~uch as albumin, than a hydrophobic surface.
One accepted explanation of this phenomenon iB a lower interfacial free enthalphy at equilibrium between the hydrophilic 6urface and the 6urrounding agueous li~uid, as compared with a hydrophobic interface and the 6urrounding aqueous liquid. The lnterfacial free enthalpy i~ the cause and driving force of sorption at the thermodynamic level.
Hydrophilic 6urfaces are usually poor 6ubstrate6 for the attachment and spreadlng of cells, particularly if the 6urfaces are highly hydrated, smooth and homogeneous. The hydrophilic 6urface i8 also les6 likely to cause protein denaturation upon : : . ~ ,. . .
.
.

.

~ 326330 its sorption. Strong and lrreversible protein sorption of hydrophobic implants may be the reason for auto-immune reactions, consecutive protein 60rption, cell adhesion and spreading, and promotion of adverse reactions of the implant.
The water-plasticized copolymers which are particularly useful in the present invention are copolymers of hydrophobic monomers 6uch as styrene, methyl styrene, methylmethacrylate, benzylmethacrylate, cyclohexylmethacrylate, viylcarbazole, vinylnaphthalene, 2-vinylthiopentene, naphthylmethacrylate, 2,6-di~chchlorostyrene, o-chlorostyrene, pentachlorophenyl methacrylate, p-methoxystyrene, diphenylmethylmethacrylate, N-(2-phenylethyl)-methacrylate, N-butylemthacrylamide, _ methacrylonitrile, acrylonitrile, vinylpyrridine, or pentabromophenyl-methacrylate, which are co-polymerized with hydrophilic monomer6 6uch as acrylamide, N-methylacrylamide, acrylic acid, methacrylic acid, vinylpryyolidone, maleic acid, methacrylamide, glyceryl acrylate or methacrylate, mono-, di- or tri-ethyleneglycol monoacrylate or methylacrylate, 2-amino-ethylacrylate or methacrylate vinyl alcohol, or vinyl sulfonic acids or 6alts.
The good shape memory required by the present invention can be best achieved by covalent cross-linking. The cross-linking of many polymer BystemB iB well known in -the art and is not the ob~ect of this invention. For instance, the cross-linking can be achieved by chain transfer during polymerization; by ,' : , : ' ' . ' ' , , -': . ',, .
.~ , ' :

copolymerization with polyfunctional co-monomers; by post- cross-linking of polymers via reactions of side groups with various polyfunctional compounds such as aldehydes, epoxides, diisocyanates and the like.
The cross-linking agents are particularly important in the above-mentioned water-plasticized copolymers formed by at least one hydrophobic and at least one hydrophiiic co-monomer. The cross-linking, in this case, is preferably caused by the presence of a monomer with two or more polymerizable double bonds, such as glycol diacrylate or dimethacrylate, where "glycol" means a molecule with l to 6 ~-OCH2CH2-) units; divinylbenzene:
methylene-bis-acrylamide; diallylphthalate;
_ phenylallylmethacrylate; N-allylmethacrylamide;
allylmethacrylate; vinylmethacrylate and N-vinylmethacrylamide, or glycerol di- or tri-acrylate or methacrylate. The cross-linking density has to be appropriate to the particular polymer system. If the cross-linking density is too high, then the polymer may be too rigid or brittle to be deformed with Tg. If the cross-linking density is too low, the shape memory may be too low or too slow for achievement of recovery to be useful in an IOL. The appropriate cross-linking density can be readily found by those skilled in the art for a specific polymer system. As a rule, one link per l00 to 500 monomer units is sufficient, although it can be as low as l link per l000 units or as high as l link per 20 units for a particular polymer.

: .

- ,. , -A particularly preferred material for use in IOLs according to the present invention is a terpolymer consisting of a hydrophobic monomer, a hydrophil~c monomer and a minor concentration, less than 5% and more preferably less than 2~, of a monomer with at least two polymerizable double bonds.
Particularly preferred are terpolymers where both hydrophilic and hydrophobic monomers form homopolymers w~th a Tg higher than about 50C, more preferably higher than about 80C. Another material requirement i8 absence of permanent deformation above about 36C. This iB another reason for the preference in the cross-linked polymers. Additionally preferred are polymers which are amorphous, without a 6ubstantial amount of crystalline - polymer phase. The absence of the crystalline phase can be detected, for instance, from an X-ray diffraction pattern of the polymer.
Optical clarity in the vi6ible spectral range iB a natural requirement related to the polymer homogeneity. A suitable polymer may have heterogeneities such as polymer domains with different compositions and refractive indecies. However, as long as these heterogeneities are ~mall enough compared with wavelength of visible llqht, for example, smaller than about 400 nm, their presence can be beneficial because of thelr intensive light scattering in the W region. The size of the domains can be kept in the aforementioned range even with incompatible moieties, e.g., hydrophilic and hydrophobic monomer units or . ~

.
: : . . .~ . -sequences, if the minor component is pre6ent in an amount lower than about 40 mol %. In addition, polymer cross-linking can diminish the size of the domains in certain polymer systems.
The beneficial effects of high surface hydration on protein sorption, general biocompatibility and surface lubricity have been discussed above. It is preferred that the lens of the present invention have a surface layer with a water content of over 50%, more preferably over about 90%. The surface properties of the lens are thereby improved without diminishing its shape retention capability or shape memory of the basic polymer at a temperature below T~. This ls in contrast to the in situ swelling IOLs which have to be inserted in the dehydrated ~tate.
- The highly hydrophilic layer, particularly the dehydrated layer, tends to adhere strongly to tissues. Accordingly, it should be avoided in in sltu 6welling IOLs. Because the IOL, whether made from a hydrophobic or hydrophilic polymer, iB already in an equilibrlum state during insertion, it can be readily equipped with a permanent or a temporary layer which has a high water content. The temporary layer may be, ~or instance, a coating of an aqueou~ 601ution of hyaluronic acid salt6 or a 6imilarly useful viscoelastic solution.
The permanent hydrogel layer can be made by surface hydrophilization by some of the methods which are well known in the art for various polymers. The surface hydrophilization can be based on oxidation, hydrolysis, transesterification and the ; . , -. - . :.

-.

like. As long as the swelling gradient thus formed is regular, the optical properties of the IOL do not deteriorate and the optical quality is rather insensitive to the thickne~s of the hydrophilic layer. The swelling gradient also causes the S formation of a refractive index gradient, which, in turn, decreases the reflection of incoming light.
The permanent hydrogel layer can also be made by encapsulation of the IOL in a highly swollen hydrogel. As long as the surface water content i6 higher than about 90%, and preferably higher than 95%, the refractive index of ~uch a layer is sufficiently close to that of vitreous humor so that the outside surface geometry or quality becomes optically - insignificant. These highly hydrated hydrogel polymers are softand their presence does not affect the IOL material's Ts.
Accordingly, the highly hydrated hydrogel polymers do not adversely affect the retention of the Insertion Configuration by the lens or its return to the Optical Configuration.
The preferred hydrogel6 in the outside layer, whether formed by chemical modification, encapsulation or by another method, are those containing negatively charged groups, such as carboxyls, sulfo-groups, 6ulphate or phosphate groups. The hydrogels in the outer layer of the lens can be either cross-linked chemically or physically and may or may not contain a crystalline polymer phase. Since the hydrogel layer does not significantly affect the IO~'s mechanical characteristics, the limitations and .. ..
: . . , j .

- . .

-1 3~6330 preferences discu6sed in ~onnectlon with the basic IOL material do not entirely apply for the hydrogel layer (with the exception of nontoxicity, biocompatibility, optical clarity and the like).
As mentioned above, the hydrogel layer thicknes6 is not important per se, but practical considerations limit the thickness of the hydrogel layer to between about 1 to 100 microns, and usually between about 5 and 50 microns.
The hydrogel layer can have various thicknesses in various parts of the IOL. For instance, the layer can be very thin in the central optical zone and the thickest in the peripheral parts or haptics. For in~tance, the outside shape of the hydrogel layer ~ay be planar, with refraction taking place between the _ hydrogel layer and the actual encapsulated IOL.
An important component of each IOL i6 the so-called haptic, or the part designed for IOL attachment to the internal eye 6tructures, e.g., capsule or ciliary body. The haptics can have various de6igns and configurations and they can be made from the ~ame material as the optical part, or from a different material, e.g., polypropylene threads. Encapsulation of the haptics in an inert hydrogel can solve numerous biocompatibility problems often related to haptics.
The IOLs of the present invention can use various designs of haptics. It is preferred however that haptics are more readily deformable than the optical parts of the IOL. This way, the in vivo capsule contractions do not deform the optical zone of . , . . , : , ~ . ~ . . . .
. - ., the lens. In addition, it i6 preferred that the haptics can be deformed more readily in the plane perpendicular to the optical axis than in other directions. In such configurations, the capsule contractions do not push the lens toward the iris, which is very sensitive to contact with foreign materials. One example of haptics design with these preferred properties are the incomplete loopc or S-shaped protrusions of the IOL polymer, integral with the optical part, encapsulated in a much softer hydrogel with a high water content. Some examples of IOL designs for both anterior and posterior implantation, 6uitable for the present invention, are shown in Figures 2 to 8.
The IOL, according to the present invention, can be reshaped _ to the 6hape appropriate for insertion ("Insertion Configuration") at any time during or after manufacture, but prior to insertion. For instance, the IOL can be brought into the "Insertion Configuration" as part of the manufacturing process. In this case, the IOL would have to be constantly kept at low temperatures, including during the 6teps of ~terilization, shipment and storage. Therefore, it is advantageous to Gonstruct the package in such a way that the "Insertion Configuration" i6 maintained in the package, regardless of temperature. This can be done by keeping the IOL in a clamp or in a cavity in the package having a 6hape which matches the 6hape of the "Insertion Configuration". In this way, the package can be autoclaved in the "~nsertion Configuration" and 6tored or shipped at a temperature higher than Ts~

~ , -.: , : ~ : - : - .-Another approach is to package, autoclave and ship the IOL
in its "Optical Configuration" and transform the IOL into the "Insertion Configuration" after opening the sterile package just prior to the surgery. Because the transfer from the "Optical" to the "Insertion Configuration" is very fast and 6imple, this transformation can be done by a nurse or a 6urgeon without a problem. The procedure includes several simple steps:
l) placing the undeformed IOL into a shaping tool:
2) heating the tool and device above T6 (usually higher than 37C, preferably about 50~) in an appropriate medium, such as warm sterile saline:
3) compressing the IOL into its Insertion Configuration - shape;
4) cooling the IOL and the tool below T6;
5) removing the rigid IOL in Insertion Configuration from the tool;
6) applying a viscoelastic agent, if needed, and inserting the lens in Insertion Configuration through the incision by means of forceps, a tubular applicator, or the like.
In place of Step 3, being a compressing step, the IOL may be stretched along it~ longitudinal axis (i.e., direction of insertion). A combination of compre6sion and 6tretching may also be used.
The shaping tool can be a simple 6terile, disposable device, or a more complicated sterilizable device. The cooling and , , ~ ., . ~ ................. . .

,, ~ , . . . , ~ , ~ .
... . .

heating of the IOL can be done by immersing the tool with the IOL
into an appropriate sterile medium (preferably isotonic saline), or it can be caused by internal heating and/or cooling elements of the shaping tool. The shaping tool can al~o be designed to S facilitate or to perform the insertion of the IOL into the eye.
Some simple shaping tools are described in the Examples.
The novel method of implantation of the IOL, according to the present invention, is convenient for the patient and for the surgeon. Both the size of the incision and the time necessary for implantation are diminished in comparison with the alternative methods.
The intraocular lens, according to the present invention, is _ reshaped at a temperature above T5 into a shape suitable for itsinsertion, cooled below Ts to fix the In~ertion Configuration, and maintained below Ts until it i6 inserted into the eye. Once implanted, the lens is heated to the body temperature which is above Ts, which causes the lens to return to its Optical Configuration. The return to the Optical Configuration is faster than the return caused by swelling, so that the position of the lens can be checked and altered during surgery. More importantly, the lens is always in osmotic equilibrium with vitreous humor so that any transient, nevertheless potentially harmful conditions of protein sorption and tissue adhesion are avoided.

. . - ~ ~ ~ . , :

;

1 3'26330 The lens can also be used in connection with viscoelastic agents, and provided with an outside hydrophilic layer. Thus, the lens can be inserted into the eye with the hydrogel layer in a fully swollen, lubritious 6tate. This way, all disadvantages of the IOL swelling in situ, discus6ed in The Descri~tion of The Related Art are avoided. Moreover, the lens can be shaped for insertion immediately prior to surgery by a very fast and simple procedure. Accordingly, the insertion shape can be customized for the particular ~urgical technique, in a particular situation and according to the preference of a particular surgeon. Custom deformation of the IOL cannot be done with a lens deformed in a non-swollen tate.
_ The shape for insertion can be 6elected 60 that the m~nimum cross- ection is achieved without bending or folding the optical zone. The most preferred shape i~ achieved by compression against the edges as indicated in Figure lA, lA' (Optical Configuration and cross-section) and lB, lB' (Insertion Configuration and cross-section).
Another preferred reshaping method iB the extension of the lens in the direction lateral to the smallest final cross-section as indicated in Figures lA and lC (Optical and Insertion Configuration, respectively).
These two methods can be advantageously combined BO that the lens is simultaneously reshaped by extension in the direction of haptics and by compression by an appropriately shaped tool , ' against the len~ edges perpendicular to the extension. The type of reshaping described above is far superior to folding or bending because the deformation is evenly distributed through the lens. Therefore, a ~ubstantial change of overall shape is achieved without any large local deformation.
In addition, when assuming its Optical Configuration, there is no part of the lens which has to travel over long distances through a highly viscous medium; which is the case with IO~s that are inserted by folding and assume their Optical Configuration by unfolding.
Therefore, the present invention solves not only the problem of in6ertion through a 6mall inci6ion, but more importantly, the _ problem of a fast and 6afe return of the IOL into $ts Optical Configuration.
One 6ub6tantial advantage of the present invention over insertion of a deformed elastic lens, described in the prior art, is that the IOL iB inserted in IC while it i8 rigid and non-elastic. Therefore, it maintains its 6hape which ls optimum for insertion without any mechanical means or tool6. The shaping tool and the insertion tool may be different instruments, each optimized for a 6ingle purpose. The rigid and non-elastic IOL in the I~ increases convenience to the surgeon as well as decreases the ri6k of accidental and sudden decompre6sion. Accidental and 6udden decompre6sion may occur when an elastic lens i6 forcefully compressed during insertion, resulting in loss of control of the lens and possible injury to the patient.

;

' ~ 3~6330 The lens, according to the present invention, is suitable for insertion not only by means of forceps or other holding instruments, but also by means of various tubular applicators, injector~, and the like. Use of these applicators makes the IOL
insertion a faster, more efficient and a less traumatic procedure.
EXAMPLE I
100 grams of n-butylmethacrylate (nBMA), free of inhibitor, were mixed with l.l grams of ethylenglycoldimethacrylate (EGDM) and 0.05 grams of azo-bi~-isobutyronitrile (ABIN). The mixture was purged with nitrogen and poured into polypropylene molds which were made from disposable plastic syringes.
_ The molds filled with a polymerization mixture, were heated in a water bath to 65C for five hours, and then the temperature was increased to 90C for four hours to decompose the rest of the initiator and to complete the polymerization. The blocks of cross-linked Poly nBMA were then removed from the molds, cut into disks about 2 mm thick and lO mm in diameter.
The disks were extracted in ethyl alcohol in a Soxhlet apparatus for several hours to remove unincorporated residues, dried in an oven at 80C, and then dried under vacuum at 60C to a constant weight. Scme of the clear disks of the cross-linked Poly nBMA were cooled in a water-ice mixture and lathed to form a biconvex IOL having a diameter of 6 mm. The lathing and polishing was readily done as long as the polymer was cooled below about 12 to 15C and held ln a precooled chuck.

- ;. : .: -, , ~ ..

1 3~6330 The refractive index of the polymer was 1.484, as measured by usin~ an Abbe refractometer on a thin slice of the polymer.
The radius of curvature was 14.9 mm. The refractive power was determined to be +21 Diopters, as measured by a Vertexometer in a wet cell filled with saline. The edge thickness of the lens was 0.15 mm and its central thickness was 0.76 mm. The undeformed cross-section in an axial plane had an area of 3.35 ~quare mm.
The lens was inserted into the cavity of a length of natural rubber tubing with an I.D. of 4 mm and a wall thickness of 3 mm.
The tubing was then heated in a water bath to about 60C, extended to about seven times its length, and cooled while _ extended in a water-ice mixture. The tubing was relaxed and the deformed IOL was readily removed. The lens had a roughly cylindrical 6hape with a length of about 6.5 mm, a diameter of about 1.6 mm and a cross-sectional area of about 2 mm2. The lens was readily insertable through a facoemulsification incision (3.3 x 1.6 mm, and a cross-sectional area of about 4.2 mm2~. Once heated to 37C in 6aline, the IOL recovered to its exact original shape, dimensions and optical parameters. The whole procedure was repeated several times without any observable deterioration of the lens quality.
Disks of IOL material with a diameter of 10 mm and a thickness of 2 mm were used to determine the T8 of the polymer in the following way:

~ . ~. ., - - ~

- .. . .

1) A dlsk and a stainless 6teel pln (O.D. = 1.5 mm) were heated in saline to about 50 to 60C for about 5 minutes;
2) The disk was wrapped tightly around the pin, quenched in saline at a temperature of 0C for about 5 minutes;
53) The pin was placed in the cooled saline horizontally, with folded side of the disk turned down, and the temperature of the saline was 810wly increased (1C every 2 to 3 minutes);
4) At a certain temperature, the disk partially unfolded and fell to the bottom of the container; this temperature was 10recorded as T61;
5) At a slightly higher temperature, the disk returned to its original flat ehape, with no observable re6idual deformation.
_ This temperature was recorded as T82;
6) The softening temperature was calculated as Ts=
15(Tsl+Ts2)/2.
In this particular Example, Tsl was found to be 18.5C and T82 was 23C, so that T8=20.75C.
EXAMPLE II
85 grams of benzyl Acrylate, 15 grams of styrene and 0.35 20grams of tetraethyleneglycol-bis-methacrylate were polymerized under nitrogen by means of 0.075 grams of benzoylperoxide.
Temperature was kept at 65C for the first 19 hours, and then the temperature was raised to 110C for 4 hours.
The polymer disks were again used to determine Ts as 25described in Example I. The Ts was 25.5C and the refractive index was 1.570.

.

.. . .. . ., .: - :

The copolymer was lathed into the shape of a biconvex lens having a diameter of 6 mm, a radius of curvature of 15.67 mm and edge thickness of 0.15 mm. The lens had a ref~active power in saline immersion of +31.5 Diopters. Its central thickness is 0.73 mm, and its area of cross-6ection in the axial plane is 3.22 mm .
The lens was then inserted in a tube made from a roll of stainles~ 6teel~ 0.5 mm in thickness. The roll and the lens were immer~ed in nearly boiling water for 6everal seconds, and the rdll wa6 tightened until its I.D. wa~ less than about 1.6 mm.
Then the roll containing the deformed lens was immersed in a jar of 6aline at a temperature of about 10C for 6everal seconds.
_ The roll was slightly unwound to 1006en the deformed lens, which wa6 readily removed. The lens in the deformed state was about 6.6 mm long. The lens had a nearly cylindrical cross-6ectional diameter of about 1.6 mm; and a cro6s-6ectional area of le6s than 2 mm2. The deformed len6 wa6 readily insertable through a facoemulsification incision by means of forceps or another 6uitable instrument.
Introduction of the lens into the eye may also be accomplished by means of a tubular instrument, 6uch as a canula or a syringe needle. Also the deformation tool, i.e., the metal sheet roll, could be used to insert the lens through the incision.

After insertion, the lens was heated to at least 36C, the reshaped lens completely recovered its original shape, dimensions and optical parameter~, i.e., it~ Optical Configuration.
EXAMP~E III
To demonstrate the difference between the lens of the present Lnvention, and a lens according to the current state of the art, a biconvex lens was made from medical grade silicon rubber (refractive index 1.42). Its radius of curvature was 5.67 mm, its diameter was 6.0 mm, its edge thickness was 0.15 mm, and its central thickness was 1.87 mm. Its area of cross-section in the axial plane was 7.9 mm2, nearly twice the area of the facoemulsification incision.
_ The silicone rubber lens was placed into the instrument described in Example II, which was tightened with considerable force until its diameter was less than about 2.3 mm, 60 that it barely fitted into the incision, the cross-sectional area of the deformed lens was about 4.1 mm2. An attempt was made to push the lens out of the instrument with a pin. Although the lens waR
lubricated, the lens could not be pushed until the roll was unwound to an I.D. of about 2.4 to 2.5 mm. As the lens exited the instrument, it was damaged a~ it expanded over the edge.
When it was more than 50% out of the instrument, the lens popped out fast in an uncontrollable manner.
In another experiment, the lens was folded into a taco-like shape using forceps, and an attempt was made to insert the lens through a ~imulated incision with an elliptical hole measuring 3.3 x 1.6 mm. Insertion was utterly impossible. A comparison with Example II ~how~ that the handling and. the use of the IOL
according to the present invention is safer and more convenient than the handling and use of optically ~imilar 6ilicone IOLs.
EXAMPLE IV
35 grams of methylmethacrylate was mixed with 65 grams of 2-hydroxyethacrylate containing 0.85 wt. % of ethylene-glycol dimethacrylate. 0.05 grams of azo-bis-isobutyronitrile were dissolved in the mixture, which was then purged briefly with nitrogen. The solution was drawn into polypropylene ~yringes, enclosed and heated in water, containing about 0.25~ 60dium _ bisulfide, to 70C for 12 hours. The solut$on in the syringes polymerize~ without bubbles or vacuole~ since the plunger compensated for contractions in the volume of the solution.
The hard plastic cylinders thus formed were readily removed from the molds, i.e., syringes, heated in an oven for 12 hours to 105C at atmospheric pressure and then for another 12 hours at 0.3 Torr.
Thereafter, the cylinders were slowly cooled to ambient temperature. The polymer at this polnt was hard, and had a softening temperature of about 100C. It was readily lathed and polished into the shape of biconvex IOL with integral haptics.
The finished lens was then placed in an isotonic saline ~olution for 24 hours at ambient temperature. From the lens' .
.,: . , .

. ~ .
: : .

weight increase it was found that its equilibrium water content was about 10% by weight. The final parameters of the lens were as follows: Diameter: 6.0 mm; radius of curvature: 14.02 mm;
central thickness: 0.80 mm; edge thickness: 0.16 mm: undeformed area of cros6-section: 3.5 mm2; and, refractive power in saline immersion: 20.75 Diopters. The refractive index of the pol~mer in equilibrium with 6aline was 1.475.
The lens was inserted into the opening of the deform~tion tool schematically depicted in Figure 9. The lens and tool were then heated by brief immersion into sterile saline at a temperature of about 65C.
The ~aws of the tool were then closed as 6hown in Figure 10, _ and the tool including the lens were quenched for several seconds in iced 6aline. The tool was then opened and the lens, in the deformed cylindrical shape, was readily removed.
The length of the deform lens' optical part measured about 6.5 mm, it had a diameter of about 1.6 mm and its cross-sectional area was about 2.1 mm2. The lens in this state was rigid, readily handable and insertable through a small incision.
Unlike a dry-deformed hydrogel lens, this lens could be covered with aqueous lubricants or viscoelastic agents, as long as they were precooled below the T5 of the polymer, approximately 22 to 25C. Once heated to 37C, the lens returned into its original shape and geometry.

~-.

EXAMPLE V
80 grams of 2-hydroxyethylmethacrylate, with a dimethacrylate content of 0.35 wt %, was copolymerized with 20 grams of methylmethacrylate as described in Example IV. The resulting copolymer was equally capable of being lathed and polished as the copolymer of Example IV with the higher NMA
content.
The copolymer was in equilibrium with saline and plasticized with about 19 wt % of saline. The copolymer, plasticized with 6aline had a T6 at about 9 to 11C. The lens could be deformed at ambient temperature and quenched in ice-cooled saline. The lens had to be inserted ln the eye through the incieion w$thout _ substantial delay. Once it was beyond the critlcal, i.e., the narroweet, point of entry, the lene recovered its original shape within 6everal second6 80 that it could be manipulaed inside the eye as an ordinary, zlbeit, a soft IOL. The advantage of the fast shape recovery i8 that surgeon can check the position and fixation of the lens without undue delay.
EXAMPLE VI
Several terpolymere were prepared with one common compound, ethyleneglycoldimethacrylate (1% by wt). The other two monomer componente were:
ethylmethacrylate ~36%)-n-hexylmethacrylate (63%);
n-butylmethacrylate (94%) - methylmethacrylate (63%):
methylacrylate (89%) - styrene (10%);
methylacrylate (55%) - methylmethacrylate ~11%);

' 1 326330 n-butylacrylate (55%) - methykmetacrylate (44%);
cyclohexylacrylate (94~) - cyclohexylacrylate (5%);
methylacrylate (79%) - ethylmethacrylate (20%);
ethylacrylate (59%) - ethylmethacrylate (40%);
glycolmonomethacrylate (59%) - methylmethacrylate (40%).
All of these terpolymers were found to have a T8, when immersed in water, at the useful working range of 15C to 30C.
In addition, all these terpolymers completely recovered their original ~hape at 36C after being deformed at temperatures below their Td, i.e., they exhibited complete memory.

'4 : . ~ `

Claims (13)

1. In an intraocular lens which includes at least a non-toxic, biocompatible, hydrolytically and enzymatically stable, photodegradation resistant, polymeric optical zone portion, where in the improvement comprises said polymeric optical zone portion having the following characteristics, when in osmotic equilibrium with body liquids:
a) softening temperature Ts between about 0° and about 42°C;
b) damaging temperature Td higher than 42°C;
c) refractive index greater than 1.39; and d) temperature range of elastic deformation Te, above Ts but below Td, and when said polymeric optical zone portion is heated to Te and one of its original dimensions is reduced by at least 20%, then cooled to at least 5°C below Ts and, upon reheating to Te said polymeric optical zone portion will return to its original dimensions existing prior to said first heating to Te, dimensional reduction and cooling.
2. A lens in accordance with Claim 1 wherein said polymeric material is plastizable by water or isotonic aqueous solution containing a biocompatible solute.
3. A lens in accordance with Claim 1 wherein the polymer is a co-polymer derived from at least two co-monomers.
4. A lens in accordance with Claim 3 additionally comprising a cross-linking agent.
5. A lens in accordance with Claim 3 wherein at least one of the co-monomers is hydrophilic.
6. A lens in accordance with Claim 3 wherein at least one of the co-monomers is hydrophobic.
7. A lens in accordance with Claim 6 wherein at least one of the co-monomers is hydrophilic.
8. A lens in accordance with Claim 2 comprising an outer hydrogel layer capable of maintaining a water content greater than 90% by weight when inserted in the eye.
9. A lens in accordance with Claim 8 wherein the thickness of the hydrogel layer is between 1 and 100 microns after swelling.
10. A sterile package comprising:
a lens of Claim 1, a dimension reducing means capable of reducing the dimension of said lens by at least 20% of its prereduction dimension, in a predetermined direction, after heating to a temperature above Ts and below Td and autoclavable encapsulating means surrounding said lens and said clamping means.
11. A package according to Claim 10 wherein said lens is located within said clamping means.
12. A package according to Claim 11 wherein said lens is in said Optical Configuration.
13. A package in accordance with Claim 11 wherein said lens has been reduced by at least 20% of its pre-reduction dimension in a predetermined direction in said Optical Configuation and is maintained in said reduced state by said dimension reducing means.
CA000552538A 1986-11-26 1987-11-23 Intraocular lenses Expired - Fee Related CA1326330C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/935,224 US4731079A (en) 1986-11-26 1986-11-26 Intraocular lenses
US935,224 1986-11-26

Publications (1)

Publication Number Publication Date
CA1326330C true CA1326330C (en) 1994-01-25

Family

ID=25466739

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000552538A Expired - Fee Related CA1326330C (en) 1986-11-26 1987-11-23 Intraocular lenses

Country Status (7)

Country Link
US (1) US4731079A (en)
EP (1) EP0269288B1 (en)
JP (1) JPS6415042A (en)
AT (1) ATE72623T1 (en)
AU (1) AU601520B2 (en)
CA (1) CA1326330C (en)
DE (1) DE3776762D1 (en)

Families Citing this family (155)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808182A (en) * 1986-11-26 1989-02-28 Nestle, S.A. Deswelled, hydrogel intraocular lenses
CS264604B1 (en) * 1986-12-19 1989-08-14 Sulc Jiri Syntetic,in hydrocare swelling,intraocular lens
US4988352A (en) * 1987-03-26 1991-01-29 Poley Brooks J Method and apparatus for folding, freezing and implanting intraocular lens
US4834750A (en) * 1987-09-17 1989-05-30 Ioptex Research, Inc. Deformable-elastic intraocular lens
US4813954A (en) * 1987-10-09 1989-03-21 Siepser Steven B Compression, deformation, dehydration method of fabrication and implantation of an expansile, hydrogel intraocular lens
US4863539A (en) * 1987-11-06 1989-09-05 Optical Radiation Corporation Haptic attachment for intraocular lenses
US5258490A (en) * 1987-12-14 1993-11-02 Chang Sing Hsiung Non-irritating soft gas permeable contact lens and process for producing same
US4851003A (en) * 1988-01-05 1989-07-25 Lindstrom Richard L Corneal implant lens with fixation holes
CS269158B1 (en) * 1988-04-01 1990-04-11 Sulc Jiri Hard intraocular eyeglass with elastic memory
CS271606B1 (en) * 1988-04-11 1990-10-12 Sulc Jiri Intraocular optical system
US5273750A (en) * 1988-05-02 1993-12-28 Institute National De La Sante Et De La Recherche Medicale- Inserm Uncrosslinked hydrogel, process for its preparation and its uses as an article for medical and/or surgical purposes such as tubes, films, joints, implants and the like, particularly in ophthalmology
FR2630638B1 (en) * 1988-05-02 1997-08-08 Inst Nat Sante Rech Med EYE IMPLANT AND ITS PREPARATION METHOD
US4919662A (en) * 1988-09-16 1990-04-24 Minnesota Mining And Manufacturing Company Hydrogel implant lens construction reconfigured dehydrated re-hydrated in situ
US5080924A (en) * 1989-04-24 1992-01-14 Drexel University Method of making biocompatible, surface modified materials
FR2655270B1 (en) * 1989-12-05 1994-10-28 Ceskoslovenska Akademie Ved INTRAOCULAR LENS IN SHAPE MEMORY HYDROGEL.
GB2238723B (en) * 1989-12-07 1994-04-27 Ceskoslovenska Akademie Ved Intraocular hydrogel lens with shape memory
US5269813A (en) * 1990-06-12 1993-12-14 Menicon Co., Ltd. Material for one-piece intraocular lenses
US5290892A (en) * 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5217489A (en) * 1991-04-05 1993-06-08 Alcon Surgical, Inc. Bifocal intraocular lens
EP0514096A3 (en) * 1991-05-13 1993-03-31 Ioptex Research Inc. Deformable-elastic intraocular lens
US5476513A (en) * 1992-02-28 1995-12-19 Allergan, Inc. Intraocular lens
US5201763A (en) * 1992-02-28 1993-04-13 Allergan, Inc. Thin intraocular lens
US6692525B2 (en) 1992-02-28 2004-02-17 Advanced Medical Optics, Inc. Intraocular lens
US5197981A (en) * 1992-04-23 1993-03-30 Alcon Surgical, Inc. Intraocular lens having haptic of specific curvature and proportion
US5480950A (en) * 1992-09-28 1996-01-02 Kabi Pharmacia Ophthalmics, Inc. High refractive index hydrogels and uses thereof
US5316704B1 (en) * 1992-09-28 1996-05-21 Kabi Pharmacia Ophthalmics Inc Process for fabricating full sized expansible hydrogel intraocular lenses
US5964744A (en) * 1993-01-04 1999-10-12 Menlo Care, Inc. Polymeric medical device systems having shape memory
US5578082A (en) * 1994-05-27 1996-11-26 Allergan IOL for optimal capsular bag fit
US5439950A (en) * 1994-06-27 1995-08-08 Kabi Pharmacia Ophthalmics, Inc. Water miscible non-hydrolyzable cross-linkers and high refractive index hydrogels prepared therewith
JP2967093B2 (en) * 1995-02-23 1999-10-25 ホーヤ株式会社 Flexible intraocular lens
US5925294A (en) * 1996-04-24 1999-07-20 Hoya Corporation Process for the production of an intraocular lens
JP3075985B2 (en) * 1996-04-24 2000-08-14 ホーヤ株式会社 Method for manufacturing intraocular lens
US5922821A (en) * 1996-08-09 1999-07-13 Alcon Laboratories, Inc. Ophthalmic lens polymers
US5944725A (en) * 1996-09-26 1999-08-31 Bausch & Lomb Surgical, Inc. Method and apparatus for inserting a flexible membrane into an eye
FR2765797B1 (en) * 1997-07-08 1999-11-26 Corneal Ind FLEXIBLE MONOBLOCK INTRAOCULAR IMPLANT
FR2766699B1 (en) * 1997-08-01 1999-11-26 Corneal Ind FLEXIBLE MONOBLOCK INTRAOCULAR IMPLANT
US6786928B2 (en) * 1997-08-20 2004-09-07 Thinoptx, Inc. Small incision lens
US6800091B2 (en) * 1997-08-20 2004-10-05 Thinoptx, Inc. Method of using a small incision lens
DE19738345C1 (en) * 1997-09-02 1999-05-06 Mdp Medical Device Polymers Gm intraocular lens
US6371960B2 (en) 1998-05-19 2002-04-16 Bausch & Lomb Surgical, Inc. Device for inserting a flexible intraocular lens
US6468306B1 (en) 1998-05-29 2002-10-22 Advanced Medical Optics, Inc IOL for inhibiting cell growth and reducing glare
EP1166155A1 (en) * 1999-03-23 2002-01-02 Medennium, Inc. Polymeric material compositions and intraocular lenses made from same
US8247511B2 (en) * 1999-04-12 2012-08-21 Advanced Vision Science, Inc. Water plasticized high refractive index polymer for ophthalmic applications
US6281319B1 (en) * 1999-04-12 2001-08-28 Surgidev Corporation Water plasticized high refractive index polymer for ophthalmic applications
US6200626B1 (en) * 1999-05-20 2001-03-13 Bausch & Lomb Incorporated Surface-treatment of silicone medical devices comprising an intermediate carbon coating and graft polymerization
WO2001005578A1 (en) * 1999-07-16 2001-01-25 Wesley-Jessen Corporation Thermoformable ophthalmic lens
US6451056B1 (en) * 1999-08-09 2002-09-17 J. Stuart Cumming Lens for increased depth of focus
US6406739B1 (en) 2000-01-12 2002-06-18 Alcon Universal Ltd. Coating compositions and methods for reducing edge glare in implantable ophthalmic lenses
JP2001252300A (en) * 2000-03-14 2001-09-18 Mototsugu Nishinobu Method for replacing crystalline lens substance
US6679605B2 (en) * 2000-05-22 2004-01-20 Medennium, Inc. Crystalline polymeric compositions for ophthalmic devices
US20020022882A1 (en) * 2000-08-17 2002-02-21 Morgan Courtney Flem Rollable intraocular lens having reduced thickness
US6695880B1 (en) * 2000-10-24 2004-02-24 Johnson & Johnson Vision Care, Inc. Intraocular lenses and methods for their manufacture
US20040151755A1 (en) * 2000-12-21 2004-08-05 Osman Rathore Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use
US6884261B2 (en) * 2001-01-25 2005-04-26 Visiogen, Inc. Method of preparing an intraocular lens for implantation
US6846326B2 (en) 2001-01-25 2005-01-25 Visiogen, Inc. Connection geometry for intraocular lens system
US6855164B2 (en) * 2001-06-11 2005-02-15 Vision Solutions Technologies, Llc Multi-focal intraocular lens, and methods for making and using same
US20050119739A1 (en) * 2001-06-11 2005-06-02 Vision Solution Technologies, Llc Multi-focal intraocular lens, and methods for making and using same
US7229475B2 (en) 2001-06-11 2007-06-12 Vision Solutions Technologies, Inc. Multi-focal intraocular lens, and methods for making and using same
US20070265650A1 (en) * 2001-07-23 2007-11-15 Ioannis Pallikaris Device for separating the epithelial layer from the surface of the cornea of an eye
US7156859B2 (en) * 2001-07-23 2007-01-02 Fos Holding S.A. Device for separating the epithelium layer from the surface of the cornea of an eye
WO2006017835A2 (en) * 2004-08-06 2006-02-16 Sightrate B.V. Device for separating the epithelial layer from the surface of the cornea of eye
EP1408901A1 (en) * 2001-07-23 2004-04-21 FOS Holding S.A. Device for separating the epithelium layer from the surface of the cornea of an eye
US20030095230A1 (en) * 2001-08-02 2003-05-22 Neely Frank L. Antimicrobial lenses and methods of their use related patent applications
US20030060878A1 (en) * 2001-08-31 2003-03-27 Shadduck John H. Intraocular lens system and method for power adjustment
US20050021139A1 (en) * 2003-02-03 2005-01-27 Shadduck John H. Ophthalmic devices, methods of use and methods of fabrication
US10045844B2 (en) * 2002-02-02 2018-08-14 Powervision, Inc. Post-implant accommodating lens modification
US8048155B2 (en) 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US7261737B2 (en) * 2002-12-12 2007-08-28 Powervision, Inc. Accommodating intraocular lens system and method
US20070100445A1 (en) * 2003-02-03 2007-05-03 Shadduck John H Intraocular lenses and business methods
US20080299179A1 (en) * 2002-09-06 2008-12-04 Osman Rathore Solutions for ophthalmic lenses containing at least one silicone containing component
US20040150788A1 (en) 2002-11-22 2004-08-05 Ann-Margret Andersson Antimicrobial lenses, processes to prepare them and methods of their use
US6593451B1 (en) 2002-10-09 2003-07-15 Pragtech, Inc. Method of processing polyacrylonitrile
US20040070107A1 (en) * 2002-10-09 2004-04-15 Pragtech, Inc. Method of making lubricious polyacrylonitrile artificial joint components and resulting product
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US7217288B2 (en) * 2002-12-12 2007-05-15 Powervision, Inc. Accommodating intraocular lens having peripherally actuated deflectable surface and method
US8361145B2 (en) * 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
US7247168B2 (en) * 2002-12-12 2007-07-24 Powervision, Inc. Accommodating intraocular lens system and method
US20040260321A1 (en) * 2002-12-19 2004-12-23 Ming-Kok Tai Apparatus and method for separating the epithelium layer from the cornea of an eye without corneal pre-applanation
US7615056B2 (en) * 2003-02-14 2009-11-10 Visiogen, Inc. Method and device for compacting an intraocular lens
AU2004219674A1 (en) * 2003-03-06 2004-09-23 Powervision, Inc. Adaptive optic lens and method of making
EP1644473B1 (en) * 2003-06-03 2014-01-15 Cantimer Incorporated Phase change sensor
DE10349254A1 (en) * 2003-10-20 2005-05-12 Transmit Technologietransfer Intraocular lens device for improving vision in retinal diseases
US7416737B2 (en) * 2003-11-18 2008-08-26 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
US20050133949A1 (en) * 2003-12-19 2005-06-23 Pragtech, Inc. Polymer solidification and coating process
WO2005065592A1 (en) * 2003-12-30 2005-07-21 Bausch & Lomb Incorporated Improved iol inserter plunger
US7645300B2 (en) 2004-02-02 2010-01-12 Visiogen, Inc. Injector for intraocular lens system
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
US8133274B2 (en) * 2004-06-18 2012-03-13 Medennium, Inc. Photochromic intraocular lenses and methods of making the same
US20050283164A1 (en) * 2004-06-18 2005-12-22 Henry Wu Apparatus and method for implanting intraocular lens through a small incision
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
US8377123B2 (en) * 2004-11-10 2013-02-19 Visiogen, Inc. Method of implanting an intraocular lens
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
EP1871306A4 (en) 2005-04-01 2012-03-21 Univ Colorado A graft fixation device and method
US20070088433A1 (en) * 2005-10-17 2007-04-19 Powervision Accommodating intraocular lens system utilizing direct force transfer from zonules and method of use
US20070100446A1 (en) * 2005-10-27 2007-05-03 Donald Horvatich Intraocular lens
US8657877B2 (en) * 2005-11-14 2014-02-25 Vision Solutions Technologies, Inc. Multi-focal prosthesis, and methods for making and using same
EP2353553B1 (en) * 2006-05-12 2015-12-02 Covidien LP Implant and delivery system with multiple marker interlocks
KR101484928B1 (en) * 2006-06-01 2015-01-21 어드밴스드 비젼 사이언스, 인코포레이티드 A non- or reduced glistenings intraocular lens and method of manufacturing same
US7789509B2 (en) * 2006-06-01 2010-09-07 Advanced Vision Science, Inc. Non- or reduced glistenings intraocular lens and method of manufacturing same
US20080001320A1 (en) 2006-06-28 2008-01-03 Knox Wayne H Optical Material and Method for Modifying the Refractive Index
US9681947B2 (en) * 2006-10-23 2017-06-20 Novartis Ag Intraocular lens delivery system with temperature control
US8900249B2 (en) 2006-10-23 2014-12-02 Novartis Ag Method of delivering temperature controlled intraocular lens
JP5399254B2 (en) * 2006-10-31 2014-01-29 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド Preparation process of antibacterial contact lenses
US7968650B2 (en) * 2006-10-31 2011-06-28 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
US20080102095A1 (en) 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
US20080100797A1 (en) * 2006-10-31 2008-05-01 Nayiby Alvarez-Carrigan Antimicrobial contact lenses with reduced haze and preparation thereof
US8403984B2 (en) 2006-11-29 2013-03-26 Visiogen, Inc. Apparatus and methods for compacting an intraocular lens
US20080306587A1 (en) * 2007-02-21 2008-12-11 Jingjong Your Lens Material and Methods of Curing with UV Light
US8158712B2 (en) * 2007-02-21 2012-04-17 Powervision, Inc. Polymeric materials suitable for ophthalmic devices and methods of manufacture
JP5426547B2 (en) * 2007-07-23 2014-02-26 パワーヴィジョン・インコーポレーテッド Lens delivery system
US9610155B2 (en) 2008-07-23 2017-04-04 Powervision, Inc. Intraocular lens loading systems and methods of use
WO2009015226A2 (en) 2007-07-23 2009-01-29 Powervision, Inc. Accommodating intraocular lenses and methods of use
US8668734B2 (en) 2010-07-09 2014-03-11 Powervision, Inc. Intraocular lens delivery devices and methods of use
US8314927B2 (en) * 2007-07-23 2012-11-20 Powervision, Inc. Systems and methods for testing intraocular lenses
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
US8425595B2 (en) 2008-03-12 2013-04-23 Visiogen, Inc. Method for inserting an intraocular lens
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
EP2384167A4 (en) * 2009-01-09 2016-02-17 Powervision Inc Intraocular lenses and methods of accounting for capsule size variability and post-implant changes in the eye
AU2010249415A1 (en) 2009-05-22 2011-12-15 Abbott Medical Optics Inc. Ophthalmic lenses with enhanced surface and methods of fabrication thereof
JP5894076B2 (en) * 2009-08-31 2016-03-23 パワーヴィジョン・インコーポレーテッド Lens capsule size estimation method
JP2013520291A (en) 2010-02-23 2013-06-06 パワーヴィジョン・インコーポレーテッド Liquid for accommodation type intraocular lens
US8697770B2 (en) 2010-04-13 2014-04-15 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
US9690115B2 (en) 2010-04-13 2017-06-27 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
US8877103B2 (en) 2010-04-13 2014-11-04 Johnson & Johnson Vision Care, Inc. Process for manufacture of a thermochromic contact lens material
WO2012122320A2 (en) 2011-03-07 2012-09-13 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer intraocular lenses
US9427493B2 (en) 2011-03-07 2016-08-30 The Regents Of The University Of Colorado Shape memory polymer intraocular lenses
WO2012143304A2 (en) * 2011-04-18 2012-10-26 Parrot Sa Liquid formulation for ophtalmic devices
US20130083287A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US20130083286A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
WO2013168410A1 (en) * 2012-05-07 2013-11-14 株式会社メニコン Intraocular lens insertion tool
ES2923570T3 (en) * 2012-09-19 2022-09-28 Roger Zaldivar intraocular lens
US20140094908A1 (en) * 2012-09-19 2014-04-03 Roger Zaldivar Intraocular lens and method
JP6023340B2 (en) * 2012-10-15 2016-11-09 ノバルティス アーゲー Low refractive index ophthalmic device material with low adhesiveness
US20140277438A1 (en) 2013-03-14 2014-09-18 Medennium, Inc. Crystalline polymeric compositions for ophthalmic devices
ES2834479T3 (en) 2013-03-15 2021-06-17 Alcon Inc Method of reconfiguring an intraocular lens for delivery to a delivery device
US9636216B2 (en) 2013-04-19 2017-05-02 Staar Surgical Company Injector cartridge with improved lubricity
CN103340703A (en) * 2013-06-17 2013-10-09 无锡蕾明视康科技有限公司 Implantable myopia lens and preparation method thereof
WO2015038940A1 (en) * 2013-09-13 2015-03-19 Abbott Medical Optics Inc. Shape memory polymer intraocular lenses
WO2016040331A1 (en) 2014-09-09 2016-03-17 Staar Surgical Company Ophthalmic implants with extended depth of field and enhanced distance visual acuity
WO2017079733A1 (en) 2015-11-06 2017-05-11 Powervision, Inc. Accommodating intraocular lenses and methods of manufacturing
BR112018068184B1 (en) 2016-03-09 2023-02-14 Staar Surgical Company LENS CONFIGURED FOR IMPLANTATION INTO A HUMAN EYE
KR102560250B1 (en) 2018-08-17 2023-07-27 스타 서지컬 컴퍼니 Polymer composition showing the refractive index of the nanogradient
US11724471B2 (en) 2019-03-28 2023-08-15 Johnson & Johnson Vision Care, Inc. Methods for the manufacture of photoabsorbing contact lenses and photoabsorbing contact lenses produced thereby
US11678975B2 (en) 2019-04-05 2023-06-20 Amo Groningen B.V. Systems and methods for treating ocular disease with an intraocular lens and refractive index writing
US11944574B2 (en) 2019-04-05 2024-04-02 Amo Groningen B.V. Systems and methods for multiple layer intraocular lens and using refractive index writing
US11564839B2 (en) 2019-04-05 2023-01-31 Amo Groningen B.V. Systems and methods for vergence matching of an intraocular lens with refractive index writing
US11529230B2 (en) 2019-04-05 2022-12-20 Amo Groningen B.V. Systems and methods for correcting power of an intraocular lens using refractive index writing
US11583389B2 (en) 2019-04-05 2023-02-21 Amo Groningen B.V. Systems and methods for correcting photic phenomenon from an intraocular lens and using refractive index writing
US11583388B2 (en) 2019-04-05 2023-02-21 Amo Groningen B.V. Systems and methods for spectacle independence using refractive index writing with an intraocular lens
JP2022531027A (en) 2019-05-03 2022-07-06 ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド High reactivity index, high Abbe composition
US11708440B2 (en) 2019-05-03 2023-07-25 Johnson & Johnson Surgical Vision, Inc. High refractive index, high Abbe compositions
WO2021067574A1 (en) 2019-10-04 2021-04-08 Alcon Inc. Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses
EP4237882A1 (en) 2020-10-29 2023-09-06 Johnson & Johnson Surgical Vision, Inc. Compositions with high refractive index and abbe number

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL145136C (en) * 1967-07-25 1900-01-01
US3996935A (en) * 1969-02-14 1976-12-14 Surgical Design Corporation Surgical-type method for removing material
US4002169A (en) * 1972-04-18 1977-01-11 Cupler Ii John A Method and apparatus for performing surgery without tissue incision
US4078564A (en) * 1976-02-24 1978-03-14 Novo Enzyme Corporation Intralenticular cataract surgery
US4191176A (en) * 1976-02-24 1980-03-04 Novo Laboratories, Inc. Intralenticular cataract surgery
US4063557A (en) * 1976-04-01 1977-12-20 Cavitron Corporation Ultrasonic aspirator
US4206518A (en) * 1977-01-31 1980-06-10 Fritz Jardon Intraocular lens device
US4113088A (en) * 1977-06-06 1978-09-12 Binkhorst Richard D Sterile package
US4253199A (en) * 1978-09-25 1981-03-03 Surgical Design Corporation Surgical method and apparatus for implants for the eye
US4254509A (en) * 1979-04-09 1981-03-10 Tennant Jerald L Accommodating intraocular implant
US4373218A (en) * 1980-11-17 1983-02-15 Schachar Ronald A Variable power intraocular lens and method of implanting into the posterior chamber
US4573998A (en) * 1982-02-05 1986-03-04 Staar Surgical Co. Methods for implantation of deformable intraocular lenses
US4466705A (en) * 1982-09-30 1984-08-21 Michelson Paul E Fluid lens
US4508216A (en) * 1983-07-14 1985-04-02 Kelman Charles D Housing for an intraocular lens and method of using the same
US4537943A (en) * 1983-07-21 1985-08-27 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4542542A (en) * 1983-07-21 1985-09-24 Innovative Surgical Products, Inc. Correction of defects in the eye and compositions therefor
US4615703A (en) * 1983-07-22 1986-10-07 Cilco, Inc. Intraocular lens delivery system
US4638056A (en) * 1983-07-22 1987-01-20 Cilco, Inc. Opthalmic wafer
US4556998A (en) * 1983-08-04 1985-12-10 Siepser Steven B Artificial intraocular lenses and method for their surgical implantation
US4664666A (en) * 1983-08-30 1987-05-12 Ezekiel Nominees Pty. Ltd. Intraocular lens implants
EP0161765B1 (en) * 1984-04-11 1988-10-05 Pharmacia Ab Ultraviolet light absorbing intraocular implants
EP0166051B1 (en) * 1984-06-28 1989-03-15 Ceskoslovenska akademie ved Process for fabricating an intraocular lens
GB8519071D0 (en) * 1984-12-18 1985-09-04 Tahan M Hydrogel-forming polymers

Also Published As

Publication number Publication date
US4731079A (en) 1988-03-15
JPS6415042A (en) 1989-01-19
EP0269288A1 (en) 1988-06-01
AU8167487A (en) 1988-06-02
DE3776762D1 (en) 1992-03-26
AU601520B2 (en) 1990-09-13
EP0269288B1 (en) 1992-02-19
ATE72623T1 (en) 1992-03-15

Similar Documents

Publication Publication Date Title
CA1326330C (en) Intraocular lenses
AU669224B2 (en) High refractive index hydrogels and uses thereof
CA2055138C (en) Polymers and their use for flexible intraocular lenses
US4452776A (en) Hydrogel implant article and method
EP0492126B1 (en) Composite intraocular lens and method of manufacture
US4863539A (en) Haptic attachment for intraocular lenses
CA1339604C (en) Synthetic intraocular lens swellable in swelling agent and a method for preparation thereof
JP2930306B2 (en) Deformable elastic intraocular lens
JP5096793B2 (en) Polymer composition and ophthalmic lens body
ES2380894T3 (en) Acrylic polymer material, hydrophobic for intraocular lens, of improved flexibility by the use of a transfer agent Acrylic polymer material, hydrophobic for intraocular lens, of improved flexibility by the use of a transfer agent
US4946470A (en) Hard intraocular lens with the shape memory
US4808182A (en) Deswelled, hydrogel intraocular lenses
US5717049A (en) High refractive index hydrogels prepared from polymers and copolymers of N-benzyl-N-methylacrylamide
KR20010033659A (en) High refractive index ophthalmic device materials
US5316704A (en) Process for fabricating full sized expansile hydrogel intraocular lenses
AU661306B2 (en) Deformable-elastic intraocular lens
EP0034174B1 (en) Hydrogel implant article and method
JPS6297559A (en) Intraocular lens material
JP2869113B2 (en) Intraocular hydrogel lens with shape memory

Legal Events

Date Code Title Description
MKLA Lapsed